Literature DB >> 11551649

HIV gp120 V(1)/V(2) and C(2)-V(3) domains glycoprotein compatibility is required for viral replication.

M Chen1, C Shi, V Kalia, S B Tencza, R C Montelaro, P Gupta.   

Abstract

The envelope gene, especially the V(3) region, of HIV-1 has been shown to be a principal determinant of cell tropism, replication and cytopathogenicity of the virus. In addition, the V(1)/V(2) region of the envelope gene has been found to be an important factor in cell tropism. We examined the compatibility between the V(1)/V(2) and C(2)-V(3) domains of HIV-1 gp120 in different combinations on viral replication by using envelope recombinants between ME1 and ME46, two infectious molecular clones with diverse biologic activity longitudinally isolated from one seropositive subject. Our data demonstrate that a proper interaction between the regions of V(1)/V(2)and C(2) is essential for viral infection and hence replication. Sequence analysis and subsequent site directed mutagenesis study indicate that the pattern of potential envelope N-glycosylation in the V(1)/V(2) and C(2)-V(3) regions may be the determining factor in such interaction between these two regions. It is possible that improper N-glycosylation sites while not affecting virus assembly, can influence through steric hindrance the conformational change of the V(3) region that is required for the co-receptor attachment and hence the viral infectivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551649     DOI: 10.1016/s0168-1702(01)00322-7

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses.

Authors:  David R M Graham; Megan J Mitsak; Steven T Elliott; Dawn Chen; Stephen A Whelan; Gerald W Hart; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2008-12       Impact factor: 3.984

2.  A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.

Authors:  Michael B Zwick; Robert Kelleher; Richard Jensen; Aran F Labrijn; Meng Wang; Gerald V Quinnan; Paul W H I Parren; Dennis R Burton
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

Authors:  Laryssa Howe; Caroline Leroux; Charles J Issel; Ronald C Montelaro
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Chicken galectin-1B inhibits Newcastle disease virus adsorption and replication through binding to hemagglutinin-neuraminidase (HN) glycoprotein.

Authors:  Junfeng Sun; Zongxi Han; Tianming Qi; Ran Zhao; Shengwang Liu
Journal:  J Biol Chem       Date:  2017-10-04       Impact factor: 5.157

5.  Replicative homeostasis: a fundamental mechanism mediating selective viral replication and escape mutation.

Authors:  Richard Sallie
Journal:  Virol J       Date:  2005-02-11       Impact factor: 4.099

6.  A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization.

Authors:  Wenbo Wang; Jianhui Nie; Courtney Prochnow; Carolyn Truong; Zheng Jia; Suting Wang; Xiaojiang S Chen; Youchun Wang
Journal:  Retrovirology       Date:  2013-02-06       Impact factor: 4.602

7.  Construction and characterization of highly infectious full-length molecular clones of a HIV-1 CRF07_BC isolate from Xinjiang, China.

Authors:  Zheng Wang; Kunxue Hong; Jing Zhang; Lei Zhang; Dan Li; Li Ren; Hua Liang; Yiming Shao
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.